Pfizer signaled Tuesday it expects a challenging 2026 as it invests in new products to offset declines in Covid-19 revenues while limiting shareholder payouts. Shares of the big drugmaker fell sharply after it projected a dip in full-year adjusted profits per share on roughly flat revenues. Pfizer expects 2026 revenues...
